Biontech Se
Clinical trials sponsored by Biontech Se, explained in plain language.
-
Early-Stage pancreatic cancer drug trial halted after just one patient
Disease control TerminatedThis study aimed to test whether adding an experimental drug called BNT321 to standard chemotherapy (mFOLFIRINOX) could help prevent pancreatic cancer from returning after surgery. It was designed for patients who had their tumor completely removed. The sponsor stopped the trial …
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Apr 04, 2026 03:36 UTC
-
BioNTech tests new cancer drug targeting specific protein in advanced tumors
Disease control TerminatedThis early-stage trial tested a new drug called BNT142 in people with advanced solid tumors that have a specific marker called CLDN6. The study aimed to find a safe dose and see if the drug could shrink tumors in patients with cancers like ovarian, lung, and testicular cancer who…
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC